The NECTA Drug Development Meeting 2024 values the support of industry and government partners in hosting this landmark event.
With thanks to our sponsorship partners for 2024:
With thanks to our sponsorship partners for 2024:
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications. Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine
For 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.msd-australia.com.au or www.msdoncology.com.au (for healthcare professionals).
Daiichi Sankyo is a global pharmaceutical company on a mission to become a global top ten leader in oncology by 2030. This was driven by the discovery of our proprietary DXd antibody drug conjugate (ADC) technology, which is poised to redefine the treatment of cancer. In Australia, we are growing a team with a passion for innovation and compassion for patients. We are working with more than 40 sites on 10 trials evaluating our DXd ADCs, with additional studies planned. We are committed to developing new ideas and innovations in partnership with local researchers, clinicians, patients, patient advocates and government to enrich the lives of those impacted by cancer.
Sponsorship packages for the upcoming Meeting are currently available.
Please contact the Organising Committee for further details on sponsorship options at: [email protected]
Please contact the Organising Committee for further details on sponsorship options at: [email protected]